Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect

Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure Mihai Gheorghiade, MD, An Thyssen, Ph. D, Robert Zolynas, DVM, MBA, Venkatesh K. Nadar, MD, Barry H. Greenberg, MD, Mandeep Mehra, MD, Xiang Sun, Ph. D, Hong Tian, Ph. D, Alexei N. Plotnikov, MD, Paul Burton, MD The Journal of Heart and Lung Transplantation Volume 30 Issue 2 Pages 218 -226 (February 2011) DOI: 10. 1016/j. healun. 2010. 08. 027 Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 1 The Journal of Heart and Lung Transplantation 2011 30218 -226 DOI: (10. 1016/j. healun. 2010. 08. 027) Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 2 The Journal of Heart and Lung Transplantation 2011 30218 -226 DOI: (10. 1016/j. healun. 2010. 08. 027) Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 3 The Journal of Heart and Lung Transplantation 2011 30218 -226 DOI: (10. 1016/j. healun. 2010. 08. 027) Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 4 The Journal of Heart and Lung Transplantation 2011 30218 -226 DOI: (10. 1016/j. healun. 2010. 08. 027) Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 5 The Journal of Heart and Lung Transplantation 2011 30218 -226 DOI: (10. 1016/j. healun. 2010. 08. 027) Copyright © 2011 International Society for Heart and Lung Transplantation Terms and Conditions